X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-09 | LH | Labcorp Holdings Inc. | Meltzer Jonathan C | EVP, Operations | S - Sale+OE | $275.53 | -88 | 2,787 | -3% | -$24,247 | |||||
| M | 2026-02-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $39.52 | -4,017 | 345,070 | -1% | -$158,757 | |||||
| M | 2026-02-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $231.20 | -4,639 | 137,847 | -3% | -$1,072,538 | |||||
| M | 2026-02-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $230.72 | -90,024 | 123,156 | -42% | -$20,770,419 | |||||
2026-02-03 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $227.83 | -6,939 | 52,120 | -12% | -$1,580,926 | ||||||
2026-02-03 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $231.02 | -3,594 | 178,081 | -2% | -$830,279 | ||||||
2026-02-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $230.77 | -435 | 306,725 | 0% | -$100,384 | ||||||
2026-02-03 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $230.77 | -1,334 | 223,813 | -1% | -$307,845 | ||||||
2026-02-03 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $20.56 | -4,441 | 125,364 | -3% | -$91,286 | ||||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $238.78 | -5,970 | 213,180 | -3% | -$1,425,506 | |||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $235.38 | -5,064 | 59,059 | -8% | -$1,191,953 | |||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $239.39 | -482 | 307,160 | 0% | -$115,388 | |||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $239.01 | -1,886 | 225,147 | -1% | -$450,773 | |||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $238.98 | -2,213 | 142,486 | -2% | -$528,853 | |||||
| M | 2026-01-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $238.98 | -1,712 | 175,540 | -1% | -$409,127 | |||||
2026-01-27 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $120.03 | -20,000 | 90,000 | -18% | -$2,400,538 | ||||||
2026-01-23 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $243.94 | -1,500 | 307,642 | 0% | -$365,914 | ||||||
2026-01-27 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.97 | -2,000 | 82,788 | -2% | -$5,940 | ||||||
| M | 2026-01-23 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $11.81 | +100,000 | 2,313,210 | +5% | +$1,180,736 | |||||
2026-01-22 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $10.96 | +82,465 | 2,213,210 | +4% | +$903,561 | ||||||
| D | 2026-01-22 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $11.50 | -1,201 | 164,458 | -1% | -$13,812 | |||||
| M | 2026-01-21 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $21.16 | -19,480 | 597,405 | -3% | -$412,223 | |||||
| DM | 2026-01-20 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $234.74 | -73,522 | 219,150 | -25% | -$17,258,853 | |||||
| DM | 2026-01-20 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $239.49 | -61,123 | 64,123 | -49% | -$14,638,100 | |||||
| DM | 2026-01-20 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $234.60 | -6,144 | 309,142 | -2% | -$1,441,367 | |||||
| DM | 2026-01-20 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $234.74 | -19,672 | 227,033 | -8% | -$4,617,888 | |||||
| M | 2026-01-20 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $234.74 | -23,498 | 144,699 | -14% | -$5,515,960 | |||||
| M | 2026-01-20 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $234.74 | -18,145 | 177,252 | -9% | -$4,259,417 | |||||
2026-01-21 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale | $114.09 | -8,571 | 20,990 | -29% | -$977,902 | ||||||
2026-01-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.01 | -4,017 | 349,087 | -1% | -$160,732 | ||||||
2026-01-15 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $21.05 | -10,156 | 616,885 | -2% | -$213,804 | ||||||
| D | 2026-01-16 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $8.15 | -83 | 1,072 | -7% | -$676 | |||||
| D | 2026-01-16 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $8.15 | -298 | 8,446 | -3% | -$2,428 | |||||
| D | 2026-01-16 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $8.15 | -298 | 7,869 | -4% | -$2,428 | |||||
| D | 2026-01-16 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $8.15 | -970 | 38,974 | -2% | -$7,905 | |||||
| D | 2026-01-16 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $8.15 | -298 | 13,654 | -2% | -$2,428 | |||||
2026-01-07 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale | $112.08 | -10,031 | 20,990 | -32% | -$1,124,279 | ||||||
| M | 2026-01-05 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $38.76 | -4,017 | 290,885 | -1% | -$155,694 | |||||
2026-01-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $228.95 | -2,951 | 123,499 | -2% | -$675,621 | ||||||
2026-01-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $229.08 | -3,848 | 136,568 | -3% | -$881,482 | ||||||
2025-12-30 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.00 | -2,000 | 84,788 | -2% | -$6,000 | ||||||
2025-12-22 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.35 | -830 | 294,902 | 0% | -$33,491 | ||||||
2025-12-19 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $225.94 | -1,500 | 268,030 | -1% | -$338,914 | ||||||
2025-12-17 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.04 | -509 | 295,732 | 0% | -$20,380 | ||||||
2025-12-17 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $39.31 | -14,888 | 109,574 | -12% | -$585,292 | ||||||
2025-12-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $101.46 | -116 | 7,993 | -1% | -$11,769 | ||||||
2025-12-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $227.01 | -3,070 | 269,530 | -1% | -$696,912 | ||||||
2025-12-15 | GH | Guardant Health, Inc. | Eltoukhy Helmy | Co-CEO | S - Sale | $103.82 | -90,565 | 2,047,143 | -4% | -$9,402,220 | ||||||
2025-12-15 | GH | Guardant Health, Inc. | Chudova Darya | CTO | S - Sale | $104.04 | -5,451 | 7,012 | -44% | -$567,132 | ||||||
2025-12-16 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $43.13 | -10,739 | 67,760 | -14% | -$463,204 | ||||||
| M | 2025-12-15 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $38.69 | -32,346 | 296,241 | -10% | -$1,251,400 | |||||
| D | 2025-12-12 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $230.76 | -4,692 | 126,450 | -4% | -$1,082,714 | |||||
2025-12-12 | NTRA | Natera, Inc. | Rosenman Herm | Dir | S - Sale | $227.42 | -48,419 | 20,342 | -70% | -$11,011,477 | ||||||
2025-12-11 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $37.48 | -13,200 | 86,825 | -13% | -$494,736 | ||||||
2025-12-11 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $37.45 | -4,496 | 50,326 | -8% | -$168,375 | ||||||
| D | 2025-12-11 | CAI | Caris Life Sciences, Inc. | Power Luke Thomas | See Remarks | S - Sale+OE | $26.58 | -62,250 | 99,571 | -38% | -$1,654,461 | |||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.31 | -4,155 | 763,926 | -1% | -$13,753 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.31 | -1,213 | 167,383 | -1% | -$4,015 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $3.31 | -892 | 118,866 | -1% | -$2,953 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.31 | -616 | 86,788 | -1% | -$2,039 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $3.31 | -1,332 | 150,397 | -1% | -$4,409 | ||||||
2025-12-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.31 | -873 | 272,214 | 0% | -$2,890 | ||||||
2025-12-08 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $105.06 | -100,000 | 419,300 | -19% | -$10,505,474 | ||||||
2025-12-08 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $104.60 | -2,000 | 22,365 | -8% | -$209,204 | ||||||
| D | 2025-12-08 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale+OE | $105.00 | -1,250 | 797 | -61% | -$131,250 | |||||
2025-12-08 | GH | Guardant Health, Inc. | Chudova Darya | CTO | S - Sale | $105.43 | -22,935 | 66,943 | -26% | -$2,417,980 | ||||||
2025-12-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.04 | -28,215 | 768,081 | -4% | -$85,774 | ||||||
2025-12-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.04 | -5,232 | 273,087 | -2% | -$15,905 | ||||||
| D | 2025-12-05 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $243.10 | -4,366 | 5,777 | -43% | -$1,061,389 | |||||
| D | 2025-12-05 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $105.69 | -3,000 | 7,789 | -28% | -$317,070 | |||||
2025-12-05 | RDNT | Radnet, Inc. | Forthuber Stephen M | Pres, COO-Eastern Operations | S - Sale | $78.33 | -45,088 | 529,221 | -8% | -$3,531,849 | ||||||
2025-12-05 | GH | Guardant Health, Inc. | Freeman Chris | Chief Commercial Officer | S - Sale | $103.07 | -31,452 | 25,987 | -55% | -$3,241,621 | ||||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Bell Michael Brian | CFO | S - Sale+OE | $103.14 | -80,362 | 28,052 | -74% | -$8,288,742 | |||||
| D | 2025-12-05 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $107.19 | -28,611 | 9,851 | -74% | -$3,066,817 | |||||
2025-12-08 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -1,560 | 19,593 | -7% | -$4,758 | ||||||
| D | 2025-12-05 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $45.45 | -20,000 | 13,554 | -60% | -$908,923 | |||||
2025-12-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.03 | -1,339 | 298,919 | 0% | -$53,600 | ||||||
2025-12-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.05 | -292 | 57,740 | -1% | -$891 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $100.00 | -13,000 | 368,818 | -3% | -$1,300,000 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $95.24 | -40,000 | 688,029 | -5% | -$3,809,535 | ||||||
2025-12-03 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $99.15 | -25,000 | 259,077 | -9% | -$2,478,818 | ||||||
2025-12-04 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $19.17 | -7,293 | 97,925 | -7% | -$139,804 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $47.30 | -1,422 | 78,499 | -2% | -$67,261 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $46.84 | -13,278 | 109,496 | -11% | -$621,955 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $47.09 | -7,668 | 318,603 | -2% | -$361,076 | ||||||
2025-12-04 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $47.51 | -1,278 | 82,113 | -2% | -$60,718 | ||||||
2025-12-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $39.23 | -2,678 | 300,258 | -1% | -$105,058 | ||||||
| D | 2025-12-01 | GH | Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | S - Sale+OE | $105.97 | -55,167 | 20,920 | -73% | -$5,846,163 | |||||
2025-12-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $238.15 | -3,000 | 109,061 | -3% | -$714,459 | ||||||
2025-12-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $238.07 | -4,400 | 140,416 | -3% | -$1,047,502 | ||||||
2025-12-02 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $28.33 | -1,140 | 557,565 | 0% | -$32,298 | ||||||
2025-12-02 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $28.33 | -1,075 | 952,890 | 0% | -$30,457 | ||||||
2025-12-02 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.93 | -2,000 | 87,404 | -2% | -$5,860 | ||||||
| D | 2025-12-02 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale+OE | $2.94 | -32,203 | 168,596 | -16% | -$94,677 | |||||
| D | 2025-12-01 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $98.13 | -1,100 | 7,789 | -12% | -$107,948 | |||||
2025-11-28 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $29.57 | -1,198 | 558,705 | 0% | -$35,424 | ||||||
2025-11-28 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $29.57 | -943 | 953,965 | 0% | -$27,884 | ||||||
2025-11-26 | ACON | Aclarion, Inc. | Ness Brent | CEO | P - Purchase | $6.20 | +10 | 11 | >999% | +$62 | ||||||
2025-11-26 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $40.09 | -4,258 | 302,936 | -1% | -$170,703 | ||||||
| D | 2025-11-25 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $10.78 | -103,668 | 164,458 | -39% | -$1,117,541 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |